{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:32:10Z","timestamp":1785461530931,"version":"3.56.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T00:00:00Z","timestamp":1228435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Cell resistance to glucocorticoids is a major problem in the treatment of nasal polyposis (NP).<\/jats:p><jats:p><jats:bold>Objectives\n\t\t\t\t\t<\/jats:bold> The objectives of this study were to observe the effect of budesonide on the expression of IL\u20101\u03b2, TNF\u2010\u03b1, granulocyte macrophage\u2010colony stimulating factor, intercellular adhesion molecule (ICAM)\u20101, basic fibroblast growth factor, eotaxin\u20102, glucocorticoid receptor (GR)\u2010\u03b1, GR\u2010\u03b2, c\u2010Fos and p65 in nasal polyps and to correlate their expression to clinical response.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Biopsies from nasal polyps were obtained from 20 patients before and after treatment with topical budesonide. Clinical response to treatment was monitored by a questionnaire and nasal endoscopy. The mRNA levels of the studied genes were measured by real\u2010time quantitative (RQ)\u2010PCR.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> There was a significant decrease in the expression of TNF\u2010\u03b1 (<jats:italic>P<\/jats:italic>&lt;0.05), eotaxin\u20102 (<jats:italic>P<\/jats:italic>&lt;0.05) and p65 (<jats:italic>P<\/jats:italic>&lt;0.05) in NP after treatment. Poor responders to glucocorticoids showed higher expression of IL\u20101\u03b2 (3.74 vs. 0.14; <jats:italic>P<\/jats:italic>&lt;0.005), ICAM\u20101 (1.91 vs. 0.29; <jats:italic>P<\/jats:italic>&lt;0.05) and p65 (0.70 vs. 0.16; <jats:italic>P<\/jats:italic>&lt;0.05) before treatment. Following treatment, IL\u20101\u03b2 (4.18 vs. 0.42; <jats:italic>P<\/jats:italic>&lt;0.005) and GR\u2010\u03b2 (0.95 vs. 0.28; <jats:italic>P<\/jats:italic>&lt;0.05) mRNA expression was higher in this group.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> Topical budesonide reduced the expression of TNF\u2010\u03b1, eotaxin\u20102 and p65. Poor responders to topical budesonide exhibit higher levels of IL\u20101\u03b2, ICAM\u20101 and nuclear factor (NF)\u2010\u03baB at diagnosis and higher expression of both IL\u20101\u03b2 and GR\u2010\u03b2 after treatment. These results emphasize the anti\u2010inflammatory action of topical budesonide at the molecular level and its importance in the treatment of NP. Nevertheless, IL\u20101\u03b2, ICAM\u20101 and NF\u2010\u03baB may be associated with primary resistance to glucocorticoids in NP, whereas higher expression of GR\u2010\u03b2 in poor responders only after glucocorticoid treatment may represent a secondary drug resistance mechanism in this disease.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2008.03144.x","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T09:29:21Z","timestamp":1228469361000},"page":"81-88","source":"Crossref","is-referenced-by-count":25,"title":["Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment"],"prefix":"10.1111","volume":"39","author":[{"given":"F. C. P.","family":"Valera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Scrideli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Tone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. T.","family":"Anselmo\u2010Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,6]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1","article-title":"Nasal polyposis","volume":"3","author":"Pawankar R.","year":"2003","journal-title":"an update"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.2500\/105065801781329446"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2001.01025.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200402-005MS"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-004-0893-y"},{"key":"e_1_2_6_7_2","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps group","volume":"20","author":"Fokkens W","year":"2007","journal-title":"Rhinology"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0385-8146(03)00051-8"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2002.1406"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.116428"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.07.011"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0280069"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(02)00263-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.1.9911032"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200308-1143OC"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200402-014MS"},{"key":"e_1_2_6_17_2","first-page":"6865","article-title":"Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative \u03b2 isoform","volume":"98","author":"Webster JC","year":"2001","journal-title":"a mechanism for the generation of glucocorticoid resistance"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02929.x"},{"key":"e_1_2_6_19_2","first-page":"183","article-title":"Staging in rhinosinusitis","volume":"31","author":"Lund VJ","year":"1993","journal-title":"Rhinology"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.124.5.513"},{"key":"e_1_2_6_21_2","first-page":"1834","article-title":"Age\u2010related patterns of immunoglobulin and T\u2010cell receptor gene rearrangements in precursor\u2010B\u2010AAL","volume":"17","author":"Van der Velden VH","year":"2003","journal-title":"implications for detection of residual minimal disease"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403110"},{"key":"e_1_2_6_24_2","first-page":"59","article-title":"Evaluation of efficacy of topical corticosteroid for the clinical treatment of nasal polyposis","volume":"45","author":"Valera FCP","year":"2007","journal-title":"searching for clinical events that may predict response to treatment"},{"key":"e_1_2_6_25_2","first-page":"367","article-title":"Interleukin\u20101\u03b2, interleukin\u20105, interleukin\u20106, interleukin\u20108, and tumor necrosis factor\u2010\u03b1 in chronic sinusitis","volume":"14","author":"Lennard CM","year":"2000","journal-title":"response to systemic corticosteroids"},{"key":"e_1_2_6_26_2","first-page":"769","article-title":"Detection of glucocorticoid receptor\u2010alpha mRNA expression using FQ\u2013RT\u2010PCR in nasal polyp","volume":"19","author":"Li P","year":"2005","journal-title":"Lin Chuang Er Bi Yan Hou Ke Za Zhi"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01745.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.7.577"},{"key":"e_1_2_6_29_2","first-page":"53","article-title":"Nuclear factor\u2010kappa B activation in the nasal polyp epithelium","volume":"112","author":"Takeno S","year":"2002","journal-title":"relationship to local cytokine gene expression"},{"key":"e_1_2_6_30_2","first-page":"279","article-title":"Nasal polyposis","volume":"14","author":"Bachert C","year":"2000","journal-title":"from cytokines to growth"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2005.01.014"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2006.55"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2008.03144.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2008.03144.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:17:01Z","timestamp":1697379421000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2008.03144.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2222.2008.03144.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03144.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}